Drug recall · July 17, 2013
Gentamicin Sulfate Injection USP 80 mg/2 mL recall
Why: Presence of Particulate Matter: visible particles were identified floating in the primary container.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Gentamicin Sulfate Injection USP 80 mg/2 mL(40 mg/mL as Gentamicin), 2 mL Single-dose Fliptop Vial, (NDC 0409-1207-13), Rx only, Manufactured by Hospira, Inc, Lake Forest, IL 60046 USA.
- Lots / codes
Lot 07-067-DK Exp. 07/13
- Quantity
- 168,300 vals
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- Nationwide
- Initiated
- May 2, 2013 · Voluntary: Firm initiated
- Classified
- July 8, 2013
- Reported
- July 17, 2013
- Ended
- October 28, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Gentamicin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.